Status:
NOT_YET_RECRUITING
Fecal Helicobacter Pylori Gene Detection for Gastric Cancer
Lead Sponsor:
Fudan University
Conditions:
Gastric Adenocarcinoma
Helicobacter Pylori
Eligibility:
All Genders
40+ years
Brief Summary
This is a prospective, multicenter, cross-sectional study. The efficacy of fecal H. pylori gastric cancer susceptibility testing in predicting gastric cancer was evaluated by comparing fecal H. pylori...
Detailed Description
Primary study objective: to assess the sensitivity and specificity of fecal H. pylori gastric cancer susceptibility locus-based testing applied to predict gastric cancer. Secondary research objective...
Eligibility Criteria
Inclusion
- Be ≥40 years of age, male or female.
- Have or will have gastroscopy and/or pathology results.
- Have no contraindications to endoscopy and be able to cooperate with endoscopy.
- Patients must be able to fully understand the informed consent form and be able to sign the informed consent form in person.
Exclusion
- Severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders.
- A previous history of upper gastrointestinal malignancy.
- Women during pregnancy.
- Those whose pathology is not clear.
- Those with unsatisfactory sample retention (e.g., too small a sample size).
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
13700 Patients enrolled
Trial Details
Trial ID
NCT06943781
Start Date
December 1 2025
End Date
December 31 2027
Last Update
June 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.